AUS
NZ
UK
CA
USA
IND
Healthcare
Why Is S&P 500 Attention Turning to Medtronic's Guidance Cut?
June 03, 2026 09:32 AM PDT| By Anmol KhazanchiMedtronic reports updated guidance, highlights performance across major medical technology segments, and continues product expansion efforts while maintaining presence in the S&P 500 Index.
Why Is Russell 1000 Attention Shifting to Merck’s Animal Health Unit?
June 03, 2026 09:31 AM PDT| By Anmol KhazanchiA lawsuit involving Merck highlights Animal Health disclosure allegations, drawing Russell 1000 Index attention to competition, product adoption trends, market position, and reporting.
Why Boston Scientific Faces New Questions Across Healthcare
June 02, 2026 09:45 PM PDT| By Anmol KhazanchiBoston Scientific is drawing attention amid evolving healthcare technology trends, structural heart developments, and broader changes across the medical device industry.
Why Established Healthcare Companies Remain Central to the Sector
June 02, 2026 10:21 AM PDT| By Anmol KhazanchiEstablished healthcare companies anchor the sector through diversified pipelines, steady cash flows and consistent demand, balancing innovation-driven growth areas within healthcare.
Why Is Biotech Attracting Attention From AI Driven Innovation
June 02, 2026 10:19 AM PDT| By Anmol KhazanchiBiotechnology attracts renewed interest as artificial intelligence shapes drug discovery discussions, combining healthcare fundamentals with emerging technology-driven innovation themes.
Why Is a Treatment Boom Driving Healthcare Stocks Higher
June 02, 2026 10:17 AM PDT| By Anmol KhazanchiExpanding treatment demand has elevated healthcare leadership, reshaped competition, and strengthened sector momentum across evolving pharmaceutical markets.
What Keeps Merck At The Center Of Global Healthcare Innovation?
June 02, 2026 12:05 AM PDT| By Anmol KhazanchiMerck continues attracting attention through its pharmaceutical research, vaccine portfolio, oncology activities, and broad participation in global healthcare markets.
Top US Health Insurance Stocks In S&P 500
June 01, 2026 05:38 PM PDT| By Anmol KhazanchiUS health insurance stocks continue to navigate medical cost pressure, Medicare Advantage challenges, regulatory changes, and evolving care models, while major managed care companies remain central to the U.S. healthcare landscape.
Top US Big Pharma Stocks Shaping Healthcare’s Next Era
June 01, 2026 01:15 PM PDT| By Anmol KhazanchiMajor pharmaceutical companies continue driving healthcare innovation through drug development, expanding therapeutic portfolios, and strategic acquisitions while navigating patent expirations, pricing pressures, and evolving regulatory frameworks.
Why Is S&P 500 Attention on Revvity After Earnings Miss?
June 01, 2026 09:42 AM PDT| By Anmol KhazanchiRevvity drew attention through earnings developments, research tools, laboratory innovation, diagnostic technologies, and broader life sciences trends shaping the S&P 500 Index.
Why Did NYSE Composite Investors Track GSK Voting Rights Update?
June 01, 2026 09:16 AM PDT| By Anmol KhazanchiGSK released a voting rights update detailing share capital structure, treasury shares, regulatory disclosures, and corporate governance transparency across NYSE Composite companies.
Why Is NYSE Composite Spotlighting AMN’s Strong Earnings Growth?
June 01, 2026 09:00 AM PDT| By Anmol KhazanchiAMN Healthcare Services remained in focus following quarterly results as healthcare staffing, workforce technology, and broader healthcare services activity influenced NYSE Composite performance.
Why Pfizer's Oncology Strategy Is Drawing Renewed Attention
June 01, 2026 12:20 AM PDT| By Anmol KhazanchiPfizer continues attracting attention as oncology research, strategic collaborations, and clinical development activities influence the global pharmaceutical industry.
Can S&P 500 Access Expansion Drive Eli Lilly Obesity Growth?
May 31, 2026 08:46 AM PDT| By Anmol KhazanchiEli Lilly’s expanding obesity treatment access, clinical research activity, and healthcare coverage developments highlight evolving pharmaceutical sector dynamics within the S&P 500 Index.
Microbot Medical Draws Attention Amid Healthcare Stock Growth
May 30, 2026 11:40 AM PDT| By Anmol KhazanchiMicrobot Medical continues advancing medical robotics innovation with strong cash reserves and a lengthy operational runway. The company's financial flexibility supports ongoing development efforts within the evolving healthcare technology sector.
Novo Nordisk Valuation Story Deepens After Recent Stock Moves
May 30, 2026 11:34 AM PDT| By Anmol KhazanchiNovo Nordisk remains in focus as mixed share returns, strong earnings signals, GLP medicine demand, valuation debate, and pricing concerns shape market attention.
Big Biotech Leaders With Established Therapy Strength
May 29, 2026 03:06 PM PDT| By Anmol KhazanchiBig biotech leaders continue anchoring healthcare through established therapies, specialized treatment areas, resilient patient demand and research pipelines that shape future disease-care relevance across major markets.
Is STERIS Valuation Reset Opening A New Debate?
May 29, 2026 12:17 PM PDT| By Anmol KhazanchiHealthcare valuation debate has intensified as recent weakness meets recurring demand, margin visibility, cost pressure and premium multiple questions across essential medical services and sterilization markets.
Eli Lilly Gains Momentum as Weight-Loss Drug Access Expands
May 29, 2026 11:33 AM PDT| By Anmol KhazanchiHealthcare access remains a critical factor within obesity treatment markets as expanded coverage supports broader patient availability, strengthens treatment adoption pathways and highlights evolving dynamics across pharmaceutical innovation.
Bruker Momentum Builds Across Life Sciences Tools Market
May 29, 2026 07:36 AM PDT| By Anmol KhazanchiBruker gained attention after stronger quarterly results, resilient scientific instrument demand, and broader research tools momentum supported by life sciences innovation and laboratory automation trends.
